We are thrilled to announce a significant milestone for Data Lake: the long-awaited launch of the Data Lake Chain – powered by Arbitrum Orbit! We are releasing the Data Lake Chain initially as a public Testnet, with the Mainnet scheduled to go live later this year.
Warsaw, June 11, 2024 Press Release Data Lake, an innovative startup specializing in medical data management, partners with Sanofi Polska, a leader in the pharmaceutical industry. The aim of this partnership is to create the first patient registry in Poland for the rare disease ASMD (Acid Sphingomyelinase Deficiency) based on patient consent. ASMD is an ultra-rare genetic disorder characterized by the accumulation of sphingomyelin in cells, leading to damage to internal organs such as the liver, spleen, and lungs.
Since our inception in 2019, Data Lake has been dedicated to unlocking the potential of medical data to advance healthcare research. We are thrilled to announce the next significant step to fulfill our mission and much more. Brace yourself: today marks the beginning of our journey to launch our very own blockchain, or the Data Lake Chain! With the launch of the Data Lake Chain, we are set to redefine the possibilities of blockchain, ushering in a new era of
We are thrilled to announce that the LAKE token will be officially listed on BitGet on Friday 22nd March at 12:00 pm UTC! This inaugural listing marks a significant milestone in our journey towards enhancing liquidity and accessibility for our community of supporters and investors. Keep reading to learn more about our journey towards the first CEX listing of LAKE and explore BitGet, one of the leading centralized exchanges (CEX) in the crypto space!
Clinical trials play a crucial role in advancing medical research and innovation, yet the process of recruiting participants presents significant challenges. Traditional recruitment strategies rely heavily on centralized databases or recruitment agencies, which often fail to reach individuals who could benefit from participation in clinical trials, thereby impeding research progress and treatment development. Moreover, the cost of patient recruitment for clinical trials is a significant component of the overall expenses, often comprising up to 40% of the total budget. On
At Data Lake, we believe in the power of collaboration and innovation to drive positive change in healthcare. Building upon the success of our inaugural program, we are thrilled to announce the launch of our second Bug Bounty initiative, offering a total budget of up to 750,000 LAKE tokens! Keep reading to learn all the details of the initiative and how to participate today!
In the landscape of medical research, the journey from patient recruitment to data acquisition has always been fraught with inefficiencies and ethical concerns. The complexities inherent in this process have led to delays, exorbitant costs, and a lack of transparency, escalating in a $100 B problem.
A disease attains the “rare” designation when affecting <1:2,000 in the European Union and <1:200,000 in the US 1. Contrary to common perception, the impact of rare diseases is substantial. Nearly 8,000 rare disorders have been identified, affecting an estimated 260–440 million individuals globally, with a notable concentration among children, constituting a prevalence rate of 3.5%–5.9% 2. These staggering figures dispel the notion of rare diseases as isolated instances and underscore their status as a significant public health concern, affecting
On December 5th, 2022, Data Lake launched its Decentralized Application (dApp) at dapp.data-lake.co to provide users with a hub to manage their $LAKE tokens. Then, in August 2023, the dApp became also the place to make it easier to create and stake LPs on Uniswap to participate to the incentives program launched in August 2023 – click here to learn more about the LP incentives program.
Abstract This case study explores the successful implementation of Data Lake’s data donation technology by Donate Your Data Foundation in the context of breast cancer research in Poland, focusing on how it facilitated the collection of crucial information regarding the patient pathway and identified roadblocks in accessing therapy. The initiative involved collaboration between healthcare institutions, technology companies, and advocacy groups, leveraging the power of data to improve the overall quality of breast cancer care.
